Stocks / Finance · Brokers & investment banks
Marex Group MRX
Outside our quality screen, so we don’t track its dips. It’s 17% below its 52-week high.
Outside our quality screen, trading near our fair value estimate.
- Fair value est.
- $69.70+7%
- Market Value
- —
- Off 52-wk high
- −17%
- Risk vs market
- Below marketbeta 0.76
4 bullish · 5 bearish See why
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 20.3×; now: P/E 16.1×.
| High | Now | |
|---|---|---|
| Price | $78.27Sep 4 | $64.90 |
| P/E | 20.3× | 16.1× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Banks, insurers and lenders: cash flow includes deposits and loans, so a cash-flow model doesn't fit; we show P/E at each point instead. P/E = that day's close × diluted shares / 12-month net income, using only the filings that were public on that day.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 25.2% ±2 points. Bear = 10.5% and 23.2%; bull = 8.5% and 27.2%. A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, MRX would need a return on equity of about 24% a year; our estimate uses 25%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much MRX moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves a bit less than the market, but its own price swings are 3.6× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.76
- Volatility
- 46% vs 13% SPY
- Correlation SPY
- 0.21
- Correlation QQQ
- 0.22
How it ranks
Where MRX stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 1 of 3 measures
- Discount to fair value estimate7% · price below our base caseTop 40%of 1,314
- Dividends + buybacks yield2.1% · cash paid out or used to retire shares, vs market capLowest 42%of 1,836
- Revenue growth, last 12 months+27% · vs the 12 months beforeTop 18%of 1,814
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $69.70
Financials model (residual income): book value $15.99 a share on Dec 31, 2025, plus the earnings above a 9.5% cost of equity. ROE 25.2%, the average of 28.7% for the fiscal year to Dec 31, 2025 and 21.7% over fiscal 2022–2025, on average common equity; payout 29% of earnings (dividends 14% + net buybacks 15%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 20-F filed Mar 25, 2026.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
GrowthSales compounded 42% a year from FY2022 to FY2025.
GrowthDiluted EPS grew 42% to $3.86 in FY2025.
GrowthSales grew 27% to $2.0B over the last 12 months vs the 12 months before (SEC filings).
ProfitabilityReturn on equity of 29% over the last 12 months.
Top bearish points 5 of 5
ValuationPrice / book of 4.1×, above the 1.7× median for the 296 Finance companies we cover.
ValuationP/E of 16.1×, above the 13.6× median for the 291 Finance companies we cover.
ProfitabilityNet margin of 15%, below the 22% median for the 281 Finance companies we cover.
QualityDoesn’t pass our quality screen: no positive free cash flow.
RiskReports earnings Nov 5 (consensus EPS $1.51): results can move the price sharply and reset Market Value.
All fundamentals
P/E 16.1 · ROE 29% · Sales +27%
Valuation
- P/E
- 16.1×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for a lender
- FCF yield
- n/acash flow isn't a clean measure for a lender
- EV / EBITDA
- n/anot meaningful for a lender
- Price / sales
- 2.34×
- Price / book
- 4.06×
- Market cap
- $4.7Bprice × diluted shares
- Enterprise value
- $2.1B
Growth
- Revenue, 12 months
- $2.0B
- Sales growth, 12 months
- +26.9%vs the 12 months before
- Sales growth, 3 yrs
- +41.7%/yrfrom FY2022
- Diluted EPS, 12 months
- $3.86
- EPS growth, last FY
- +41.9%
- Net income, 12 months
- $294M
- Net income growth
- +44%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for a lender
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 14.5%
- FCF margin
- 32.3%
- Return on equity
- 29%
- Return on invested capital
- n/anot meaningful for a lender
Balance sheet
- Cash & short-term inv.
- $2.9B
- Total debt
- $200M
- Net cash
- n/anot meaningful for a lender
- Debt / equity
- n/adeposits/float make debt/equity not comparable for a lender
- Interest coverage
- n/anot meaningful for a lender
Cash flow & returns
- Free cash flow, 12 months
- $654M
- FCF growth, 12 months
- −43%
- Dividend yield
- 1.17%$56M paid
- Payout ratio
- 19%
- Buybacks, 12 months
- $44M0.9% of market cap
- Share count, 1 year
- n/ano quarterly diluted share count
- Stock-based comp
- n/anot reported in its SEC filings
Trailing 12 months to Dec 31, 2025; balance sheet at Dec 31, 2025. From Marex Group’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
Sales +32%
- Return on equity26%
- Sales growth (latest quarter vs year-ago quarter)+32%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $64.90
- 52-wk lowlowest close, 1 year$30.35−53.2%
- PriceMon Nov 2 close$64.90you are here
- Fair value est.base case$69.70+7.4%
- 52-wk highhighest close, 1 year$78.27+20.6%
Momentum & 52-week range
RSI 37 · 5 days −8.2%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 5
- DateThu Nov 5, before the open
- Consensus EPS$1.51
- Year-ago EPS$0.96
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
MRX is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Marex Group in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Brokers & investment banks
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.